Correction to 'Integrating transcriptomics and proteomics to assess antisense oligonucleotide safety and efficacy: a time-resolved approach'. [PDF]
europepmc +1 more source
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth.
M. Dewaele +26 more
semanticscholar +1 more source
From N-of-1 to versatility in propionic acidemia: Antisense oligonucleotide-mediated skipping of a constitutive <i>PCCA</i> pseudoexon. [PDF]
Totsune E +10 more
europepmc +1 more source
Improved targeted delivery of antisense oligonucleotide with an antibody mask. [PDF]
Hsia HE +22 more
europepmc +1 more source
FACS-based dual fluorescence reporter assay demonstrates efficacy of antisense oligonucleotide therapy of novel <i>PRPF3</i> intronic splice variant. [PDF]
Dolgin V +5 more
europepmc +1 more source
Nanocarriers of Antisense Oligonucleotides in Diabetes [PDF]
Rapini, N +2 more
openaire +2 more sources
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.
G. Monteleone +21 more
semanticscholar +1 more source
Antisense Oligonucleotide Therapy for Amyotrophic Lateral Sclerosis (ALS): An Umbrella Review. [PDF]
Jeong E, Li D.
europepmc +1 more source
Glycogen for Smyd3-antisense oligonucleotide delivery and enhanced liver cancer gene therapy. [PDF]
Bai N +5 more
europepmc +1 more source

